1. Pfizer

    0 Comments Leave a Comment

    1-15 of 81 1 2 3 4 5 6 »

    1. Mentioned In 81 Articles

    2. Sonnet BioTherapeutics Appoints Ms. Lori McNeill to the Board of Directors and Formalizes the Company's Business Advisory Committee

      Explore Industry BoardMoves
      Sonnet BioTherapeutics Appoints Ms. Lori McNeill to the Board of Directors and Formalizes the Company's Business Advisory Committee
      Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), a clinical-stage company developing targeted immunotherapeutic drugs, announced today that Lori McNeill has been appointed to the Company's Board of Directors. Ms. McNeill's Board position will also round out the composition of the company's Business Advisory Committee (BAC), where she will serve as the Chairperson...
      Read Full Article
      Mentions: Nasdaq Pfizer Women on Boards
    17. 1-15 of 81 1 2 3 4 5 6 »
  1. Search:

  2. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content

  3. Related Topics

    1. Yahoo! Names Thompson CEO
      169 articles also mentioned Board of Directors
    2. Shantanu Narayen Elected To Pfizer's Board Of Directors
      102 articles also mentioned CEO
    3. NEOMED Institute Announces Inaugural Board of Directors
      56 articles also mentioned Board
    4. Chrysler Adds Two to Board
      37 articles also mentioned AT&T
    5. Thompson Joins Microsoft Board
      37 articles also mentioned Johnson & Johnson

  4. Quotes about Pfizer

    1. We are pleased to welcome Shantanu Narayen to Pfizer's Board of Directors. He brings both leadership experience and a strong technology background to Pfizer's Board and will be an excellent asset to the company.
      Ian Read in Shantanu Narayen Elected To Pfizer's Board Of Directors
    2. We are pleased to have Jim Smith join Pfizer's Board of Directors. He brings leadership and operational and international business experience to Pfizer's Board, and will be an excellent asset to the company.
      Ian Read in James C. Smith Elected to Pfizer’s Board of Directors
    3. Amy is a recognized leader in the development and growth of global pharmaceutical businesses, and she will bring this expertise to our Board as we continue to build Alnylam as a leading biotechnology company. As the former General Counsel at Pfizer, Amy also brings deep legal expertise to our Board.
      John Maraganore in Alnylam Elects Amy Schulman to its Board of Directors